This article is more than 5 years old. Information may no longer be current.
Top 5 articles from the ASPC Congress on CVD Prevention
Click Here to Manage Email Alerts
Cardiology Today and Healio have compiled a list of the top 5 articles from the American Society for Preventative Cardiology’s Congress on CVD Prevention, held July 19 to 21 in San Antonio.
VIDEO: Sex differences, barriers persist for women with heart disease
In this video exclusive, Martha Gulati, MD, MS, FACC, FAHA, division chief of cardiology at the University of Arizona College of Medicine – Phoenix, physician executive director for Banner University Medicine Heart Institute and editor in chief of ACC’s CardioSmart, discusses the importance of considering sex-specific risk factors for CVD.
VIDEO: Deepak Bhatt, MD, MPH, highlights REDUCE-IT, treating beyond LDL lowering
Bhatt, a Cardiology Today Editorial Board Member, provides an update on recent trials, with emphasis on REDUCE-IT and icosapent ethyl (Vascepa, Amarin), and how the results “fit into the larger context” of CVD prevention.
SGLT2 inhibitors may have great potential in reducing HF in diabetes
Incidents of out-of-hospital cardiac arrest in adults are the third-highest rate of health loss due to fatal and nonfatal disease burden, according to findings published in Circulation: Cardiovascular Quality and Outcomes.
Model predicts 5-year ASCVD risk in patients on statin therapy
Researchers developed an ASCVD risk score that was shown to estimate residual ASCVD risk among adults with prior CVD who are on statin therapy.
Obesity, overweight predict HF risk in postmenopausal women despite metabolic healthPostmenopausal women with obesity or overweight had elevated risk for HF regardless of whether they were metabolically healthy or unhealthy, according to research presented at the American Society for Preventive Cardiology Congress on CVD Prevention.Read More